A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: Design of the NATIVE study.

Autor: Sven M., Francque1,2 (AUTHOR) Sven.Francque@uza.be, Pierre, Bedossa3,4 (AUTHOR), Manal F., Abdelmalek5 (AUTHOR), Quentin M., Anstee4,6,7 (AUTHOR), Elisabetta, Bugianesi8 (AUTHOR), Vlad, Ratziu9 (AUTHOR), Philippe, Huot-Marchand10 (AUTHOR), Bruno, Scherrer11 (AUTHOR), Jean-Louis, Junien10 (AUTHOR), Pierre, Broqua10 (AUTHOR), Jean-Louis, Abitbol10 (AUTHOR)
Zdroj: Contemporary Clinical Trials. Nov2020, Vol. 98, pN.PAG-N.PAG. 1p.
Databáze: Academic Search Ultimate
Externí odkaz: